What is the current stock price of Fortress Biotech, Inc.?

As of the latest update, Fortress Biotech, Inc.'s stock is trading at $2.96 per share.

What's happening with Fortress Biotech, Inc. stock today?

Today, Fortress Biotech, Inc. stock is up by 3.67%, possibly due to recent market activity.

What is the market sentiment around Fortress Biotech, Inc. stock?

Current sentiment around Fortress Biotech, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Fortress Biotech, Inc.'s stock price growing?

Over the past month, Fortress Biotech, Inc.'s stock price has increased by 28.91%.

How can I buy Fortress Biotech, Inc. stock?

You can buy Fortress Biotech, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol FBIO.

Who are the major shareholders of Fortress Biotech, Inc. stock?

Major shareholders of Fortress Biotech, Inc. include institutions such as The Vanguard Group, Inc., Opaleye Management, Inc., Merchant Wealth Partners LLC, according to the latest filings.

FBIO

Fortress Biotech, Inc.

$2.96

3.67%

Trade Ideas Performance

Latest Closed Trade Idea

$2.96

3.67%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Fortress Biotech, Inc. (FBIO)

Over the past six months, Fortress Biotech's stock has experienced several notable events. FBIO's share price was around $2.40 as of early May 2026, decreasing by 34.7% since the beginning of 2026 but increasing by 42.01% over the past year. The FDA approved ZYCUBO for Menkes disease in January 2026, and a priority review voucher was sold for $205 million in February 2026. Avenue Therapeutics entered an exclusive worldwide license agreement for ATX-04 for the treatment of Pompe Disease. Fortress Biotech reported Q3 2025 revenue of $17.6 million and EPS of $0.11. The company reported a full-year 2025 loss per share of US$0.067 and revenue of $63.26 million. Fortress Biotech is scheduled to report Q1 2026 results on May 13, 2026. Alliance Global analyst Scott Henry raised the firm's price target on FBIO to $4.50 and maintained a Buy rating. The company has a consensus rating of "Hold" with an average price target of $17.00. Shares of Fortress Biotech underwent a 1-for-15 reverse stock split on October 10, 2023.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community